Since JNK acts as either a tumor promoter in breast cancer [9] and prostate cancer [10] or a tumor suppressor in skin cancer [11] and ovarian cancer [12], it is important to fully understand the role of JNK and the underlying molecular mechanisms in each tumor in order to validate the therapeutic potential of JNK. The gene discussed is MAPK8; the disease is prostate carcinoma.